CXCL16
Basic information
Region (hg38): 17:4733533-4739928
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CXCL16 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 10 | 2 | 2 |
Variants in CXCL16
This is a list of pathogenic ClinVar variants found in the CXCL16 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-4735106-G-A | not specified | Likely benign (Dec 03, 2024) | ||
17-4735148-G-A | not specified | Likely benign (Jul 22, 2022) | ||
17-4735191-G-T | not specified | Uncertain significance (Sep 22, 2023) | ||
17-4735196-G-A | not specified | Likely benign (Aug 28, 2024) | ||
17-4735200-C-T | not specified | Uncertain significance (Jan 17, 2023) | ||
17-4735235-G-A | Benign (Feb 01, 2018) | |||
17-4735382-G-C | not specified | Uncertain significance (Oct 26, 2022) | ||
17-4735389-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
17-4735422-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
17-4735490-G-A | not specified | Likely benign (Dec 15, 2023) | ||
17-4738417-C-G | not specified | Uncertain significance (Apr 20, 2024) | ||
17-4738447-G-C | not specified | Uncertain significance (Oct 08, 2024) | ||
17-4738902-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
17-4739323-C-A | not specified | Uncertain significance (May 02, 2023) | ||
17-4739335-C-T | not specified | Uncertain significance (Jul 15, 2021) | ||
17-4739365-G-C | not specified | Uncertain significance (Dec 03, 2024) | ||
17-4739368-G-A | not specified | Uncertain significance (Jan 18, 2022) | ||
17-4739388-C-T | Benign (Feb 01, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CXCL16 | protein_coding | protein_coding | ENST00000293778 | 5 | 6397 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000345 | 0.602 | 125740 | 0 | 8 | 125748 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.346 | 140 | 152 | 0.921 | 0.00000752 | 1731 |
Missense in Polyphen | 30 | 37.974 | 0.79002 | 426 | ||
Synonymous | 0.985 | 55 | 65.1 | 0.845 | 0.00000341 | 591 |
Loss of Function | 0.768 | 8 | 10.7 | 0.747 | 4.53e-7 | 135 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000580 | 0.0000580 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a scavenger receptor on macrophages, which specifically binds to OxLDL (oxidized low density lipoprotein), suggesting that it may be involved in pathophysiology such as atherogenesis (By similarity). Induces a strong chemotactic response. Induces calcium mobilization. Binds to CXCR6/Bonzo. {ECO:0000250}.;
- Pathway
- Chemokine signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Chemokine signaling pathway;TYROBP Causal Network;Signaling by GPCR;Signal Transduction;Chemokine receptors bind chemokines;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0345
Intolerance Scores
- loftool
- 0.606
- rvis_EVS
- 0.6
- rvis_percentile_EVS
- 82.66
Haploinsufficiency Scores
- pHI
- 0.0144
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.399
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.000625
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cxcl16
- Phenotype
- hematopoietic system phenotype; neoplasm; immune system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- receptor-mediated endocytosis;chemotaxis;G protein-coupled receptor signaling pathway;regulation of signaling receptor activity;T cell chemotaxis;positive regulation of cell growth;positive regulation of cell migration;response to cytokine;response to interferon-gamma;response to tumor necrosis factor
- Cellular component
- extracellular region;extracellular space;plasma membrane;membrane;integral component of membrane
- Molecular function
- low-density lipoprotein particle receptor activity;scavenger receptor activity;chemokine activity